-
WNT5a/GSK3/β-Catenin Controls FAP Adipogenesis
2026-08-25
The reference study identifies the WNT5a/GSK3/β-catenin axis as a central regulator of adipogenic drift in skeletal muscle fibro/adipogenic progenitors. By integrating pharmacological perturbation, mass cytometry, transcriptomics, network modeling, and mouse injury models, it connects impaired WNT5a signaling with muscle fat accumulation and suggests mechanisms for preserving FAP-supported regeneration.
-
AIBP–LRP2–HDL Axis in Collateral Vessel Growth
2026-08-24
Zhu et al. identify an AIBP–LRP2–HDL–miR-223 pathway that limits the expansion of CXCR4-positive, stemlike capillary endothelial cells during collateral circulation. The study supports a two-phase model in which these cells first expand and later acquire arterial characteristics, offering a mechanistic framework for therapeutic revascularization research.
-
Cy3 NHS ester (non-sulfonated) Protocol Guide
2026-08-24
Cy3 NHS ester (non-sulfonated) provides an orange-emitting NHS ester for fluorescent labeling of primary amino groups in soluble proteins, peptides, oligonucleotides, and DNA. It is suited to workflows that can tolerate a DMSO or DMF co-solvent, but its water insolubility makes sulfonated Cy3 NHS ester alternatives preferable for especially solvent-sensitive biomolecules.
-
Protease Inhibitor Cocktail: Preserve Metabolic Signals
2026-08-23
A Protease Inhibitor Cocktail can preserve dynamic metabolic signals during tissue and cell extraction. This guide connects ANGPTL4–LPL biology with EDTA-free assay design, validation, and practical workflow decisions.
-
Phosbind Acrylamide for Phosphorylation Analysis
2026-08-22
Phosbind Acrylamide is a phosphate-binding reagent for antibody-free protein phosphorylation analysis by SDS-PAGE. The F4002 formulation is designed for phosphorylation-dependent mobility shifts, supports protein targets in the 30–130 kDa range, and complements mechanistic studies of protein phosphorylation signaling.
-
DR5 Agonists, PD-L1 Stabilization, and Tumor Immunity
2026-08-21
Mondal and colleagues identify an unanticipated immune-evasion circuit in which DR5 agonist antibodies activate caspase-8, ROCK1, and proteasome dysfunction to stabilize tumor-cell PD-L1. The study shows that disrupting the DR5–ROCK1–PD-L1 axis can improve T-cell activity, tumor regression, and survival in preclinical models, providing a mechanistic explanation for the limited clinical performance of earlier DR5 agonists.
-
G-1: Selective GPR30 Agonist Workflows
2026-08-20
Build cleaner GPR30 experiments with G-1, from nanomolar calcium and PI3K readouts to breast cancer migration and heart failure models. This guide combines practical dosing, receptor-specific controls, structure-informed validation, and troubleshooting for reproducible translational research.
-
Firefly Luciferase mRNA for Sex-Aware Assays
2026-08-20
Firefly Luciferase mRNA can do more than report transfection: it can help separate delivery and translation from sex-dependent immune outcomes. This guide presents a sex-aware assay framework using Cap1, 5-moUTP modification, and optimized poly(A) architecture.
-
Vitamin K2, NRF2/FSP1, and Osteoblast Ferroptosis
2026-08-19
A 2025 study identifies osteoblast ferroptosis as a mechanistic contributor to glucocorticoid-induced osteoporosis and shows that vitamin K2 partly restores bone architecture through the NRF2/FSP1 pathway. Its combination of mouse micro-CT, histology, osteogenic assays, and cell-based ferroptosis measurements provides a framework for linking lipid oxidative stress to impaired bone formation, while remaining preclinical.
-
IR-820 Imaging: From Dye to Data
2026-08-19
IR-820, also known as New Indocyanine Green, supports near-infrared fluorescence imaging of vascular and tumor biology. This guide focuses on the overlooked transition from visible signal to defensible diseased tissue quantification, while separating direct product evidence from findings obtained with engineered ICG nanoparticles.
-
mRNA Rescue of Niemann–Pick Disease Type C1
2026-08-18
Furtado and colleagues showed that an engineered NPC1 mRNA combining GC3 codon optimization with N1-Methylpseudouridine restored disease-relevant functions in patient-derived fibroblasts. The study links improved transcript design with stronger protein expression, cholesterol esterification, and correction of lysosomal abnormalities, while also defining important limits for translation beyond cultured cells.
-
Bispecific Antibodies for Broad Orthopoxvirus Protection
2026-08-18
The reference study maps anti-M1R and anti-B6R monoclonal antibodies and shows that antibody cocktails and engineered bispecific formats can improve antiviral activity against MPXV or VACV. Its strongest translational result is robust VACV protection in mice using a VH-CH1 switch region-inserting bispecific design, while also defining the preclinical limits of this strategy.
-
IR-820: From NIR Imaging to Translational Design
2026-08-17
IR-820, also known as New Indocyanine Green, is more than an infrared imaging reagent: it can serve as a strategic bridge between quantitative in vivo imaging and next-generation nanoplatform research. This article examines its mechanistic value, the lessons of GSH-responsive ICG nanotherapy, and the workflow decisions that matter for translational reproducibility.
-
VZV Glycoprotein E Mutations in mRNA Vaccines
2026-08-17
Cao and colleagues examined whether modifying the carboxyl-terminal trafficking motifs of varicella-zoster virus glycoprotein E could improve the immunogenicity of LNP-encapsulated mRNA vaccines. The combined C-terminal mutant produced the most consistent humoral and cellular immune responses in the study, supporting antigen trafficking as an important design variable while leaving protection and clinical translation to future work.
-
GSH-Responsive MOF Nanoparticles for Melanoma Therapy
2026-08-16
Hao et al. developed ICG-MOF-SS-AUNP12, a zirconium-based MOF nanoparticle that combines near-infrared photothermal therapy with GSH-responsive PD-1/PD-L1 blockade. The platform improved tumor-cell killing while promoting dendritic-cell maturation and immune activation, illustrating how stimulus-responsive nanocarriers can address limitations of standalone photothermal therapy.